Please assess the completion status of the following clinical trial:

Trial Title: Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DM

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Aged between 18-50 years old (male or female).~* Free from any diabetes related complications (apart from mild background diabetic retinopathy).~* HbA1c \<8.5%.~* Not taking any prescribed medication other than insulin, and treated with a stable insulin regimen composed of a combination of slow/long acting insulin (glargine or detemir) and fast-acting insulin analogues (lispro or aspart), for a minimum of 6 months before the start of the study.~* Demonstrate normal cardiac function in response to exercise.~Exclusion Criteria:~* Aged younger than 18, or older than 50 years.~* Suffering from, or diagnosed with a diabetes related complication (apart from mild background diabetic retinopathy).~* HbA1c \>8.5%.~* Currently taking prescribed medication, and not currently treated with a stable basal bolus regimen composed of a combination glargine or determir, and lispro or aspart for at least 6 months before the start of the study.~* Failure to demonstrate normal cardiopulmonary responses during exercise, or have a medical condition which could prevent completion of exercise or be exacerbated because of.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Basal dose reduction (Type: EXPERIMENTAL): Total daily basal (Glargine, Lantus, Sanofi-Aventis, or Detemir, Levemir, Novo Nordisk) reduction of 20% versus normal basal dose.

Based on this trial design, predict the completion outcome and termination type (if applicable).